Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | FBP1 | P09467 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.35 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208699 | 1.00 | HSD11B1 (0.44) | HSD11B1NFE2L2APPPTGS1FBP1 | |
| SCHEMBL3134095 | 1.00 | HSD11B1 (0.44) | HSD11B1NFE2L2APPPTGS1FBP1 | |
| SCHEMBL3126253 | 0.76 | NFE2L2 (0.46) | NFE2L2PTGS1FBP1GRIN2DGRIN3B | |
| SCHEMBL3134562 | 0.76 | HSD17B10 (0.46) | NFE2L2FBP1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL208020 | 0.76 | HSD17B10 (0.46) | NFE2L2FBP1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL3126258 | 0.76 | NFE2L2 (0.46) | NFE2L2PTGS1FBP1GRIN2DGRIN3B | |
| SCHEMBL206780 | 0.76 | CYP2A6 (0.42) | — | |
| SCHEMBL14555044 | 0.76 | HSD11B1 (0.43) | HSD11B1NFE2L2APPPTGS1FBP1 | |
| SCHEMBL3126254 | 0.76 | HSD17B10 (0.46) | NFE2L2FBP1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL3131905 | 0.76 | NFE2L2 (0.46) | NFE2L2PTGS1FBP1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293774-B2 | Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same | KYUNG NONG CORPORATION (KR) | 2012-10-23 | — | — | US | claimed |
| US-20100279871-A1 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-04 | — | — | US | claimed |
| CN-101743219-A | Optically active (R) -aryloxypropionamides and herbicidal compositions containing the same | KYUNG NONG CORP | 2010-06-16 | — | — | CN | claimed |
| EP-2183213-A2 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | Kyung Nong Corporation (KR) | 2010-05-12 | — | — | EP | claimed |
| WO-2009005297-A2 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2009-01-08 | — | — | WO | claimed |
| CN-101743219-B | Optically active (R) -aryloxypropionamides and herbicidal compositions containing the same | KYUNG NONG CORP | 2013-08-14 | — | — | CN | disclosed |
| US-8293774-B2 | Optically active (R)-aryloxypropionic acid amides and herbicidal composition comprising same | KYUNG NONG CORPORATION (KR) | 2012-10-23 | — | — | US | disclosed |
| US-20100279871-A1 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-04 | — | — | US | disclosed |
| CN-101743219-A | Optically active (R) -aryloxypropionamides and herbicidal compositions containing the same | KYUNG NONG CORP | 2010-06-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279871-A1 | OPTICALLY ACTIVE (R)-ARYLOXYPROPIONIC ACID AMIDES AND HERBICIDAL COMPOSITION COMPRISING SAME | AADAC, DDT, NOTUM | HSD11B1 1153/4885NFE2L2 2291/4885APP 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.